Page last updated: 2024-08-25

ropivacaine and colforsin

ropivacaine has been researched along with colforsin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brownlow, RC; Butterworth, JF; Cole, LR; Leith, JP; Prielipp, RC1
Amodeo, FS; Brummett, CM; Hong, EK; Janda, AM; Lydic, R1

Other Studies

2 other study(ies) available for ropivacaine and colforsin

ArticleYear
Bupivacaine inhibits cyclic-3',5'-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity.
    Anesthesiology, 1993, Volume: 79, Issue:1

    Topics: Adenylyl Cyclases; Adult; Amides; Bupivacaine; Cardiovascular Diseases; Colforsin; Cyclic AMP; Drug Interactions; Enzyme Activation; Epinephrine; Female; GTP-Binding Proteins; Humans; Kinetics; Lymphocytes; Male; Mepivacaine; Middle Aged; Models, Biological; Receptors, Adrenergic, beta; Ropivacaine; Signal Transduction; Stimulation, Chemical

1993
Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current.
    Anesthesiology, 2011, Volume: 115, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amides; Analgesia; Anesthetics, Local; Animals; Behavior, Animal; Colforsin; Cyclic Nucleotide-Gated Cation Channels; Dexmedetomidine; Dose-Response Relationship, Drug; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Hypnotics and Sedatives; Idazoxan; Male; Nerve Block; Pain Measurement; Potassium Channel Blockers; Potassium Channels; Prazosin; Pyrimidines; Rats; Rats, Sprague-Dawley; Ropivacaine; Sciatic Nerve

2011